Manufacture of pharmaceutical preparations
PHARMAVAX HOLDING AS
Revenue 2024
NOK 0
Operating profit
NOK −26,000
Equity
NOK 5.0m
Incorporated
2022
Share capital
NOK 40,000
Key figures · 2024
Current ratio
748.17
Equity ratio
99.9%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -0.5% | |
| Likviditet | ||
| Current ratio | 748.17 | |
| Working capital | 5.0m | |
| Soliditet | ||
| Equity ratio (%%) | 99.9% | |
| Debt-to-equity ratio | 0.00 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.